Matthew Pakizegee, PharmD, MS

Clinical Pathways GPS

Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease

03/16/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Matthew Pakizegee, PharmD, MS

Jonathan W Hodgson, MBA

Chad McAuliffe

Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...

...

03/16/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Engaging Patients in Care Through Greater Access to Medical Records and Clinical Pathways

04/16/2019

Shay L Ashline, PhD

Kristin LaBounty Phillips, MPH

Matthew Pakizegee, PharmD, MS

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Without interoperability of medical records between health systems, patients are the best chance for the medical system to provide continuity of care when medical records from a different health system are difficult...

...

04/16/2019

Journal of Clinical Pathways